Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Bailey

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaLung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
Obstetrics and Gynecology|December 2, 2014
Epidemiologic factors and urogenital infections associated with preterm birth in a midwestern U.S. populationWilliam A Agger, Danish Siddiqui, Steven D Lovrich, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancerHoward H Bailey, KyungMann Kim, Ajit K Verma, et al.
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Cancers|October 14, 2023
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and BeyondTaja Lozar, Israa Laklouk, Athena E Golfinos, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaLung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
Obstetrics and Gynecology|December 2, 2014
Epidemiologic factors and urogenital infections associated with preterm birth in a midwestern U.S. populationWilliam A Agger, Danish Siddiqui, Steven D Lovrich, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancerHoward H Bailey, KyungMann Kim, Ajit K Verma, et al.
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Cancers|October 14, 2023
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and BeyondTaja Lozar, Israa Laklouk, Athena E Golfinos, et al.
Pageof 6